CN102512627B - Traditional Chinese medicine composition for postoperative lung cancer - Google Patents

Traditional Chinese medicine composition for postoperative lung cancer Download PDF

Info

Publication number
CN102512627B
CN102512627B CN2011104252366A CN201110425236A CN102512627B CN 102512627 B CN102512627 B CN 102512627B CN 2011104252366 A CN2011104252366 A CN 2011104252366A CN 201110425236 A CN201110425236 A CN 201110425236A CN 102512627 B CN102512627 B CN 102512627B
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
medicine composition
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011104252366A
Other languages
Chinese (zh)
Other versions
CN102512627A (en
Inventor
于甦
孙胜波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yu Su
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011104252366A priority Critical patent/CN102512627B/en
Publication of CN102512627A publication Critical patent/CN102512627A/en
Application granted granted Critical
Publication of CN102512627B publication Critical patent/CN102512627B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for postoperative lung cancer, composed of traditional Chinese medicine raw materials in the following parts by weight: 5-20 parts of pinellia ternate, 5-20 parts of almond, 5-20 parts of radix stemonae, 5-25 parts of thunberg fritillary bulb, 10-40 parts of oldenlandia diffusa, 10-40 parts of sculellaria barbata, 10-40 parts of hairyvein agrimony, 3-10 parts of rheum officinale, 5-20 parts of radix peucedani, 10-40 parts of fried coix seeds, 5-20 parts of platycodon grandiflorum, 5-20 parts of folium mori, 5-20 parts of curcuma zedoary and 2-8 parts of fried liquorice. The traditional Chinese medicine composition disclosed by the invention has the effects of nourishing qi and enriching blood, clearing heat and detoxicating, lowering qi and dissipating stagnation, promoting blood circulation and relieving pain, as well as dissipating stasis and relieving cough; and the traditional Chinese medicine composition can strengthen and consolidate body resistance, dissipate mass, eliminate cancer toxin, improve the immune function of human body, inhibit and kill cancer cells, enhance the life quality of the patient, and prolong life time. The composition disclosed by the invention is simple and convenient in preparation, wide in medicine source, low in cost and without toxic and side effects.

Description

A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma
Technical field
The present invention relates to a kind of not pharmaceutical product of definite structure of traditional herbal medicines, especially a kind of for the postoperative Chinese medicine composition of pulmonary carcinoma.
Background technology
Pulmonary carcinoma is modal lung tumors, and sickness rate rises in recent years, and the pollution of this and environment and the increase of number of smokers are relevant.Clinically, the early stage Therapeutic Method of pulmonary carcinoma is usually take operative treatment as main.A large amount of clinical datas shows the early stage cancerous protuberance of radical surgery excision, and patient's five year survival rate can reach 80%-90%.Therefore, early stage of lung cancer patient adopts surgical result more satisfactory.But the characteristics of cancerous cell are recurrences and shift, so pulmonary carcinoma is postoperative can not adopt a casual attitude, and positive continual cure, to prevent the relapse and metastasis of cancerous cell.At present, the auxiliary treatment after operation of lung cancer mainly adopts the chemicotherapy treatment, to consolidate curative effect and to reduce patient's postoperative recurrence.But because chemicotherapy has certain damage to people's health, so the postoperative chemicotherapy of whether going of pulmonary carcinoma is to consider according to combined factors such as self healths of patient.
The after treatment of the postoperative employing traditional Chinese medical science of pulmonary carcinoma is effective.
Find through traditional Chinese medical science research: pulmonary carcinoma is postoperative exists three kinds of basic pathology situations simultaneously: namely vigour virtual loss, the expectorant blood coagulation stasis of blood, cancer poison knot are poly-.The traditional Chinese medical science will be take righting tonify deficiency, the stasis of blood alive of regulating the flow of vital energy, dissipating phlegm and resolving masses, counteracting toxic substances toxin expelling as the base therapy principle to postoperative after treatment, carry out the physiological function balance of negative and positive, QI and blood and the internal organs meridians of balance the body, the inherent resistance against diseases of enhancing body, improve immunologic function, promote hematopoietic function recovery, promote leukocyte, reach strengthening body, suppress the cancerous protuberance development, mitigate the disease, improve the quality of living, extending life, even reach the purpose of healing.
, according to theory of Chinese medical science,, for the postoperative Basic Mechanism of pulmonary carcinoma, carry out dialectical composition of prescription, to reach the purpose of controlling the state of an illness, the quality of making the life better, promoting rehabilitation.
Summary of the invention
In order to overcome the postoperative chemicotherapy treatment of pulmonary carcinoma in the prior art deficiency large to people's somatic damage, the invention provides a kind ofly prepare conveniently, cost is low, evident in efficacy, have no side effect be used for the postoperative Chinese medicine composition of pulmonary carcinoma.
The technical solution adopted for the present invention to solve the technical problems is: a kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, it is characterized in that: its raw material of Chinese medicine by following weight portion forms: Rhizoma Pinelliae 5-20 part, Semen Armeniacae Amarum 5-20 part, Radix Stemonae 5-20 part, Bulbus Fritillariae Thunbergii 5-25 part, Herba Hedyotidis Diffusae 10-40 part, Herba Scutellariae Barbatae 10-40 part, Herba Agrimoniae 10-40 part, Radix Et Rhizoma Rhei 3-10 part, Radix Peucedani 5-20 part, stir-fry Semen Coicis 10-40 part, Radix Platycodonis 5-20 part, Folium Mori 5-20 part, Rhizoma Curcumae 5-20 part, Radix Glycyrrhizae Preparata 2-8 part.
The preferred technical solution of the present invention is: a kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, it is characterized in that: its raw material of Chinese medicine by following weight portion forms: 10 parts of the Rhizoma Pinelliaes, 10 parts, Semen Armeniacae Amarum, 12 parts of the Radixs Stemonae, 15 parts of Bulbus Fritillariae Thunbergii, 30 parts of Herba Hedyotidis Diffusaes, 30 parts of Herba Scutellariae Barbataes, 30 parts of Herba Agrimoniaes, 6 parts of Radix Et Rhizoma Rhei, 10 parts of Radix Peucedanis, 30 parts of Semen Coicis of stir-fry, 12 parts of Radix Platycodoniss, 10 parts, Folium Mori, 10 parts of Rhizoma Curcumae, 3 parts of Radix Glycyrrhizae Preparatas.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the present invention in drug composition: the Rhizoma Pinelliae has the effect of drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Semen Armeniacae Amarum has expelling phlegm for arresting cough, the effect of the intestine moistening of relievining asthma, lower air to open numbness; The Radix Stemonae is returned lung meridian, has the effect of nourishing the lung to keep the adverse QI downward cough-relieving; Bulbus Fritillariae Thunbergii has the effect of removing heat-phlegm, sending down the abnormal ascending QI eliminating stagnation; Herba Hedyotidis Diffusae has the effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain; Herba Scutellariae Barbatae returns lung, liver, kidney channel, has the effect of heat-clearing and toxic substances removing, dissipating blood stasis hemostasis, subduing swelling and relieving pain; Herba Agrimoniae has the effect of astringing to arrest bleeding, preventing the attack (or recurrence) of malaria, detoxifcation; Radix Et Rhizoma Rhei has the effect of pathogenic fire purging removing food stagnancy, heat-clearing and toxic substances removing, cooling blood for hemostasis, blood stasis dispelling cough-relieving; Radix Peucedani has that dispelling wind and heat pathogens, lung qi dispersing eliminate the phlegm, the effect of sending down the abnormal ascending QI cough-relieving; Fry Semen Coicis and have that inducing diuresis to remove edema, spleen invigorating dry, the effect of arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus; Radix Platycodonis has lung qi dispersing and eliminates the phlegm, fosters the spirit of nobility and enrich blood, sharp the five internal organs, mend the effect of five kinds of over strain; Folium Mori have the effect of dispelling wind and heat pathogens, clearing away lung-heat and moistening for dryness, suppressing liver-YANG, liver heat removing and eyesight improving, cooling blood for hemostasis; Rhizoma Curcumae has the effect of circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving; Radix Glycyrrhizae Preparata has the effect of spleen reinforcing stomach function regulating, Yiqi and vein recovery.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, complement each other using, have synergism, playing altogether fosters the spirit of nobility enriches blood, the effect of heat-clearing and toxic substances removing, sending down the abnormal ascending QI eliminating stagnation, promoting blood circulation and stopping pain, dissipating blood stasis cough-relieving, reach the purpose of strengthening the body resistance, dissipation lump, eliminating cancer poison, and the promotion hematopoietic function recovery, promote leukocyte, improve patient's body's immunity, help post-operative recovery, strengthen patient's resistance.
In addition, modern pharmacology evidence: propagation or the transfer of the Rhizoma Pinelliae, Semen Armeniacae Amarum, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Herba Agrimoniae, stir-fry Semen Coicis, the equal anticancer of Radix Et Rhizoma Rhei or kill the function of cancerous cell, effectively postoperative recurrence, the transfer of prophylaxis of tumours, not only improve patient's quality of life, also extended simultaneously patient's life cycle.
The component of the present composition all adopts the botanical herbs raw material of All Pure Nature, and follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.It has that easy, the medicine source of preparation is wide, cost less, be not in hospital, no pain, without psychological pressure, the characteristics such as the easy acceptance of patient.The present invention verifies through clinical practice, its evident in efficacy reliable, the property of medicine is gentle, have no side effect, and has no side effect, effective percentage reaches 71.1%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Rhizoma Pinelliae 10g, Semen Armeniacae Amarum 10g, Radix Stemonae 12g, Bulbus Fritillariae Thunbergii 15g, Herba Hedyotidis Diffusae 30g, Herba Scutellariae Barbatae 30g, Herba Agrimoniae 30g, Radix Et Rhizoma Rhei 6g, Radix Peucedani 10g, stir-fry Semen Coicis 30g, Radix Platycodonis 12g, Folium Mori 10g, Rhizoma Curcumae 10g, Radix Glycyrrhizae Preparata 3g.
Embodiment 2
A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Rhizoma Pinelliae 20g, Semen Armeniacae Amarum 15g, Radix Stemonae 5g, Bulbus Fritillariae Thunbergii 10g, Herba Hedyotidis Diffusae 10g, Herba Scutellariae Barbatae 10g, Herba Agrimoniae 20g, Radix Et Rhizoma Rhei 5g, Radix Peucedani 20g, stir-fry Semen Coicis 40g, Radix Platycodonis 10g, Folium Mori 5g, Rhizoma Curcumae 20g, Radix Glycyrrhizae Preparata 5g.
Embodiment 3
A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Rhizoma Pinelliae 15g, Semen Armeniacae Amarum 5g, Radix Stemonae 20g, Bulbus Fritillariae Thunbergii 12g, Herba Hedyotidis Diffusae 40g, Herba Scutellariae Barbatae 20g, Herba Agrimoniae 10g, Radix Et Rhizoma Rhei 3g, Radix Peucedani 12g, stir-fry Semen Coicis 20g, Radix Platycodonis 20g, Folium Mori 12g, Rhizoma Curcumae 5g, Radix Glycyrrhizae Preparata 8g.
Embodiment 4
A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Rhizoma Pinelliae 5g, Semen Armeniacae Amarum 12g, Radix Stemonae 15g, Bulbus Fritillariae Thunbergii 25g, Herba Hedyotidis Diffusae 20g, Herba Scutellariae Barbatae 40g, Herba Agrimoniae 25g, Radix Et Rhizoma Rhei 10g, Radix Peucedani 5g, stir-fry Semen Coicis 25g, Radix Platycodonis 15g, Folium Mori 15g, Rhizoma Curcumae 12g, Radix Glycyrrhizae Preparata 2g.
Embodiment 5
A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Rhizoma Pinelliae 12g, Semen Armeniacae Amarum 20g, Radix Stemonae 10g, Bulbus Fritillariae Thunbergii 5g, Herba Hedyotidis Diffusae 25g, Herba Scutellariae Barbatae 25g, Herba Agrimoniae 40g, Radix Et Rhizoma Rhei 6g, Radix Peucedani 20g, stir-fry Semen Coicis 10g, Radix Platycodonis 5g, Folium Mori 20g, Rhizoma Curcumae 15g, Radix Glycyrrhizae Preparata 6g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament, and concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15~20 minutes, then add water and do not have approximately 5 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, boil rear with slow fire boiling 20~30 minutes; Second decocts, the water rear decoction 15~20 minutes of boiling.Twice decoction extracting juice that removes slag, merge.
A kind of for the postoperative Chinese medicine composition of pulmonary carcinoma, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to treat case 38 examples, male 23 examples wherein, female's 15 examples, 30~70 years old its age.
Two, usage and dosage: during clinical practice, the component in compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.This Chinese medicine composition potion on the one, twice extracting juice of decocting be 300ml approximately, divides sooner or later and takes for twice.Be a course for the treatment of January.
Three, criterion of therapeutical effect: the patient of above-mentioned case observes by the medication for the treatment of in 2 years, carries out efficacy evaluation.
(1) clinical improvement: health status is normal, and NC and obvious nbjective symptom and sign, take care of oneself, and can be engaged in light physical exertion;
(2) significantly improve: life can be taken care of oneself, and can carry out normal activity reluctantly, and some Sxs are arranged;
(3) part is improved: life can most ofly be taken care of oneself, but needs once in a while others to help, and can not be engaged in normal operation, and daytime, bed rest time surpassed 50%;
(4) invalid; Can't take care of oneself, can not be lying mortally sick, need specific treatment and nursing;
(5) death.
Four, therapeutic effect: in this clinical observation case, clinical improvement 7 examples, significantly improve 11 examples, and part is improved 9 examples, invalid 6 examples, dead 5 examples.Toxic and side effects does not occur during treatment.
Five, model case:
Case 1:
The Wang, female, 64 years old.Because of uncomfortable in chest, chest pain, cough, expectoration (the expectorant Huang is thick) seriously, are admitted to hospital then.The inspection Chest X-rays is shown: increased bronchovascular shadows, right lung have a high density shadow.In CT prompting right lung, lump is arranged, obscure boundary, in blood flow signal is arranged, the row excision of being in hospital, pathological section is diagnosed as pulmonary carcinoma.Because patient's body constitution is bad, go chemicotherapy, be in and take the decoction that Chinese medicine composition of the present invention produces and recuperate under medical treatment.Through the medical treatment of six courses for the treatment of, without sense of discomfort, two is just normal, and the conscious mental status is good, and emotion is happy, dormancy can, receiving can.Continue to take four medical treatments course for the treatment of, physical condition is better,, without sense of discomfort, takes care of oneself.
Case 2:
Xiao, man, 61 years old.Medical private prosecution in November, 2008 is at hospital's row upper right pulmonary carcinoma excision, and is postoperative with " CVP " scheme chemotherapy 2 times, radiotherapy more than 70 times.But recently fatigue and weak, have a dizzy spell, and neurolysis, becomes thin, coughs, through looking into the existing 1.8cm of upper left lung * 2.1cm lump.Its body constitution is poor, uncomfortable row Radiotherapy chemotherapy.Take the decoction that Chinese medicine composition of the present invention produces and recuperate under medical treatment a course for the treatment of, cough is alleviated, uncomfortable in chestly also take a turn for the better, and the malaise sx↓, appetite increases.Continue and take 3 courses for the treatment of, the state of an illness takes a turn for the better gradually.Uncomfortable in chest, cough is obviously alleviated, few expectorant, without the blood streak, and appetite, sleep, two are just all normal, and body constitution strengthens.Continue and take 2 courses for the treatment of, conditions of patients significantly improves, the mental status still can, face is moist, the strength of having spoken, life can be taken care of oneself.

Claims (1)

1. one kind is used for the postoperative Chinese medicine composition of pulmonary carcinoma, and it is characterized in that: its raw material of Chinese medicine and weight proportion are: Rhizoma Pinelliae 10g, Semen Armeniacae Amarum 10g, Radix Stemonae 12g, Bulbus Fritillariae Thunbergii 15g, Herba Hedyotidis Diffusae 30g, Herba Scutellariae Barbatae 30g, Herba Agrimoniae 30g, Radix Et Rhizoma Rhei 6g, Radix Peucedani 10g, stir-fry Semen Coicis 30g, Radix Platycodonis 12g, Folium Mori 10g, Rhizoma Curcumae 10g, Radix Glycyrrhizae Preparata 3g.
CN2011104252366A 2011-12-19 2011-12-19 Traditional Chinese medicine composition for postoperative lung cancer Expired - Fee Related CN102512627B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104252366A CN102512627B (en) 2011-12-19 2011-12-19 Traditional Chinese medicine composition for postoperative lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104252366A CN102512627B (en) 2011-12-19 2011-12-19 Traditional Chinese medicine composition for postoperative lung cancer

Publications (2)

Publication Number Publication Date
CN102512627A CN102512627A (en) 2012-06-27
CN102512627B true CN102512627B (en) 2013-11-13

Family

ID=46283879

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104252366A Expired - Fee Related CN102512627B (en) 2011-12-19 2011-12-19 Traditional Chinese medicine composition for postoperative lung cancer

Country Status (1)

Country Link
CN (1) CN102512627B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656014B (en) * 2013-12-19 2016-01-13 滨州医学院附属医院 A kind ofly treat Chinese medicine of diabetes patient's gastrointestinal function decline after abdominal operation and preparation method thereof
CN104398806A (en) * 2014-11-05 2015-03-11 杨金秀 Traditional Chinese medicinal preparation for lung cancer postoperative care, and preparation method thereof
CN104352790A (en) * 2014-11-17 2015-02-18 刘岚 Medicine for postoperative recovery of breast cancer and preparation method of medicine
CN104799171A (en) * 2015-05-07 2015-07-29 王小华 Medicinal food for gastric carcinoma patient to administrate and preparation method of medicinal food
CN105963553A (en) * 2016-05-20 2016-09-28 于学军 Medicine for preventing and treating respiratory tract complication after lung cancer operation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102114103A (en) * 2010-04-21 2011-07-06 胡海舰 Chinese medicine oral decoction for treating lung cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102114103A (en) * 2010-04-21 2011-07-06 胡海舰 Chinese medicine oral decoction for treating lung cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
北京、广州中医名家论治肺癌的专家共识及南北用药特色;王淑美等;《中国中西医结合杂志》;20110731;第31卷(第07期);977-980 *
张霆等.肺癌证治发微.《中华中医药学刊》.2007,第25卷(第07期),1467-1468.
晚期肺癌的中医药治疗;魏华等;《湖北中医杂志》;20000831;第22卷(第08期);20-21 *
王淑美等.北京、广州中医名家论治肺癌的专家共识及南北用药特色.《中国中西医结合杂志》.2011,第31卷(第07期),977-980.
肺癌证治发微;张霆等;《中华中医药学刊》;20070731;第25卷(第07期);1467-1468 *
魏华等.晚期肺癌的中医药治疗.《湖北中医杂志》.2000,第22卷(第08期),20-21.

Also Published As

Publication number Publication date
CN102512627A (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN103169904B (en) Traditional Chinese medicine composition for treating lung cancer
CN102512627B (en) Traditional Chinese medicine composition for postoperative lung cancer
CN103169883B (en) Traditional Chinese medicine for treating infantile jaundice
CN102716334B (en) Chinese medicinal composition for dispelling the cold and removing stasis
CN102512552B (en) Traditional Chinese medicine composition for treating exogenous fever
CN104645249B (en) One kind treats treating coronary heart disease and angina pectoris
CN102198181B (en) Antithrombotic and thrombosis-eliminating preparation
CN103585483B (en) Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same
CN103263606B (en) Traditional Chinese medicine composition for treating diabetic foot by foot bath nursing and application of traditional Chinese medicine composition
CN105853930A (en) Traditional Chinese medicine composition for treating depression
CN102091246B (en) Chinese medicine composition for treating myocardial infarction
CN102283996A (en) Traditional Chinese medicine composite for treating xerostomia
CN103550660B (en) A kind of Chinese medicine composition for the treatment of diabetes
CN1222364A (en) Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof
CN102626509A (en) Traditional Chinese medicine composite for curing pediatric jaundice
CN107617091A (en) A kind of Chinese medicine composition for treating cold asthma
CN106822779A (en) A kind of Chinese medicine composition of the obstruction of qi in the chest and palpitation and insomnia for treating caused by energy stagnation and blood stasis
CN102406879A (en) Chinese medicine composition for treating rhinitis
CN106177572A (en) A kind of Chinese medicine decoction treating aplastic anemia
CN104491703A (en) Oral traditional Chinese medicine composition for treating traumatic synovitis of knee joint
CN106138919A (en) A kind of Chinese medicine composition treating gastric cancer
CN104547190A (en) Traditional Chinese medicine for treating infantile jaundice
CN104758889A (en) Traditional Chinese medicine composition for treating diabetes
CN105106599A (en) Traditional Chinese medicine composition for treating viral myocarditis and preparation method thereof
CN104056196A (en) Traditional Chinese medicine composition for treating bradycardia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: YU SU

Free format text: FORMER OWNER: RONGCHENG RESEARCH INSTITUTE OF SCIENTIFIC + TECHNICAL INFORMATION

Effective date: 20131011

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Yu Su

Inventor after: Sun Shengbo

Inventor before: Sun Shengbo

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: YU SU SUN SHENGBO

Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264504 WEIHAI, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20131011

Address after: 264504, Golden Bay Industrial Park, No. 5, Shandong, Weihai, Rushan

Applicant after: Yu Su

Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No.

Applicant before: Rongcheng Research Institute of Scientific & Technical Information

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131113

Termination date: 20141219

EXPY Termination of patent right or utility model